Skip to main content

Availability of living donor optimizes timing of liver transplant in high-risk waitlisted cirrhosis patients.

Publication ,  Journal Article
Arisar, FAQ; Chen, S; Chen, C; Shaikh, N; Karnam, RS; Xu, W; Asrani, SK; Galvin, Z; Hirschfield, G; Patel, K; Tsien, C; Selzner, N; Lilly, L ...
Published in: Aging (Albany NY)
September 2, 2023

Liver transplant (LT) candidates have become older and frailer, with growing Non-alcoholic steatohepatitis (NASH) and comorbid disease burden in recent years, predisposing them for poor waitlist outcomes. We aimed to evaluate the impact of access to living donor liver transplantation (LDLT) in waitlisted patients at highest risk of dropout. We reviewed all adult patients with decompensated cirrhosis listed for LT from November 2012 to December 2018. Patients with a potential living donor (pLD) available were identified. Survival analyses with Cox Proportional Hazards models and time to LT with Competing risk models were performed followed by prediction model development. Out of 860 patients who met inclusion criteria, 360 (41.8%) had a pLD identified and 496 (57.6%) underwent LT, out of which 170 (34.2%) were LDLT. The benefit of pLD was evident for all, but patients with moderate to severe frailty at listing (interaction p = 0.03), height <160 cm (interaction p = 0.03), and Model for end stage liver disease (MELD)-Na score <20 (interaction p < 0.0001) especially benefited. Our prediction model identified patients at highest risk of dropout while waiting for deceased donor and most benefiting of pLD (time-dependent area under the receiver operating characteristic curve 0.82). Access to LDLT in a transplant program can optimize the timing of transplant for the increasingly older, frail patient population with comorbidities who are at highest risk of dropout.

Duke Scholars

Published In

Aging (Albany NY)

DOI

EISSN

1945-4589

Publication Date

September 2, 2023

Volume

15

Issue

17

Start / End Page

8594 / 8612

Location

United States

Related Subject Headings

  • Severity of Illness Index
  • Living Donors
  • Liver Transplantation
  • Liver Cirrhosis
  • Humans
  • End Stage Liver Disease
  • Developmental Biology
  • 1112 Oncology and Carcinogenesis
  • 0606 Physiology
  • 0601 Biochemistry and Cell Biology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Arisar, F. A. Q., Chen, S., Chen, C., Shaikh, N., Karnam, R. S., Xu, W., … Bhat, M. (2023). Availability of living donor optimizes timing of liver transplant in high-risk waitlisted cirrhosis patients. Aging (Albany NY), 15(17), 8594–8612. https://doi.org/10.18632/aging.204982
Arisar, Fakhar Ali Qazi, Shiyi Chen, Catherine Chen, Noorulsaba Shaikh, Ravikiran Sindhuvalada Karnam, Wei Xu, Sumeet K. Asrani, et al. “Availability of living donor optimizes timing of liver transplant in high-risk waitlisted cirrhosis patients.Aging (Albany NY) 15, no. 17 (September 2, 2023): 8594–8612. https://doi.org/10.18632/aging.204982.
Arisar FAQ, Chen S, Chen C, Shaikh N, Karnam RS, Xu W, et al. Availability of living donor optimizes timing of liver transplant in high-risk waitlisted cirrhosis patients. Aging (Albany NY). 2023 Sep 2;15(17):8594–612.
Arisar, Fakhar Ali Qazi, et al. “Availability of living donor optimizes timing of liver transplant in high-risk waitlisted cirrhosis patients.Aging (Albany NY), vol. 15, no. 17, Sept. 2023, pp. 8594–612. Pubmed, doi:10.18632/aging.204982.
Arisar FAQ, Chen S, Chen C, Shaikh N, Karnam RS, Xu W, Asrani SK, Galvin Z, Hirschfield G, Patel K, Tsien C, Selzner N, Cattral M, Lilly L, Bhat M. Availability of living donor optimizes timing of liver transplant in high-risk waitlisted cirrhosis patients. Aging (Albany NY). 2023 Sep 2;15(17):8594–8612.

Published In

Aging (Albany NY)

DOI

EISSN

1945-4589

Publication Date

September 2, 2023

Volume

15

Issue

17

Start / End Page

8594 / 8612

Location

United States

Related Subject Headings

  • Severity of Illness Index
  • Living Donors
  • Liver Transplantation
  • Liver Cirrhosis
  • Humans
  • End Stage Liver Disease
  • Developmental Biology
  • 1112 Oncology and Carcinogenesis
  • 0606 Physiology
  • 0601 Biochemistry and Cell Biology